TOBECHUKWU CLOUDEN: Open Payments
NPI 1669603387 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 39 payments from 8 companies in 2025. Trend: 2023 $724 · 2024 $899 · 2025 $821
Food & beverage: $634Education: $187
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $341 |
| Janssen Pharmaceuticals, Inc | 10 | $172 |
| Neurocrine BioSciences, Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Alkermes, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ABBVIE INC. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, SPRAVATO, UZEDY, COBENFY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
